Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of Clinical Pharmacology
|
February 26, 2013
The combination of exposure-response and case-control analyses in regulatory decision making
Jun Yang, Hong Zhao, Christine Garnett, et al.
The Oncologist
|
May 8, 2026
Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products
Ye Xiong, Robyn Konicki, Jeanne Fourie Zirkelbach, et al.
The Oncologist
|
May 4, 2026
Shifting a Paradigm: Highlights of Model Informed Drug Development in Dosage Selection and Optimization for Oncology Products
Ye Xiong, Robyn Konicki, Jeanne Fourie Zirkelbach, et al.
Bioanalysis
|
February 7, 2012
US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical Consortium
Fabio Garofolo, Josée Michon, Virginie Leclaire, et al.
Pharmaceutical Research
|
April 27, 2007
Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays
C T Viswanathan, Surendra Bansal, Brian Booth, et al.
The AAPS Journal
|
April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment
Marian Kelley, Lauren Stevenson, Michaela Golob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2008
Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies
Robert J Lechleider, Edvardas Kaminskas, Xiaoping Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases
Amna Ibrahim, Nancy Scher, Grant Williams, et al.
Oncology
|
June 10, 2010
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation
Michael Brave, Ann Farrell, Sue Ching Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Sorafenib for the treatment of advanced renal cell carcinoma
Robert C Kane, Ann T Farrell, Haleh Saber, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of Clinical Pharmacology
|
February 26, 2013
The combination of exposure-response and case-control analyses in regulatory decision making
Jun Yang, Hong Zhao, Christine Garnett, et al.
The Oncologist
|
May 8, 2026
Shifting a paradigm: highlights of model informed drug development in dosage selection and optimization for oncology products
Ye Xiong, Robyn Konicki, Jeanne Fourie Zirkelbach, et al.
The Oncologist
|
May 4, 2026
Shifting a Paradigm: Highlights of Model Informed Drug Development in Dosage Selection and Optimization for Oncology Products
Ye Xiong, Robyn Konicki, Jeanne Fourie Zirkelbach, et al.
Bioanalysis
|
February 7, 2012
US FDA/EMA harmonization of their bioanalytical guidance/guideline and activities of the Global Bioanalytical Consortium
Fabio Garofolo, Josée Michon, Virginie Leclaire, et al.
Pharmaceutical Research
|
April 27, 2007
Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assays
C T Viswanathan, Surendra Bansal, Brian Booth, et al.
The AAPS Journal
|
April 30, 2015
Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment
Marian Kelley, Lauren Stevenson, Michaela Golob, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2008
Ixabepilone in combination with capecitabine and as monotherapy for treatment of advanced breast cancer refractory to previous chemotherapies
Robert J Lechleider, Edvardas Kaminskas, Xiaoping Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 12, 2003
Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases
Amna Ibrahim, Nancy Scher, Grant Williams, et al.
Oncology
|
June 10, 2010
FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation
Michael Brave, Ann Farrell, Sue Ching Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 26, 2006
Sorafenib for the treatment of advanced renal cell carcinoma
Robert C Kane, Ann T Farrell, Haleh Saber, et al.
Page
of 5